Anti-TNFα therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat

American Journal of Surgery

Volumn 171, Issue 2, 1996, Pages 274-280

  Hughes, Christopher B ^a   Grewal, Hani P ^a   Gaber, Lillian W ^a   Kotb, Malak ^a   El Din, Abou Bakr Mohey ^a   Mann, Linda ^a   Gaber, A Osama ^a,b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; ANTIIDIOTYPIC ANTIBODY;

ACUTE PANCREATITIS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SURVIVAL RATE; ACUTE DISEASE; ANIMAL; DISEASE MODEL; IMMUNOLOGY; PANCREATITIS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; DISEASE MODELS, ANIMAL; MALE; PANCREATITIS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029664603     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)89568-2     Document Type: Article

References (38)

1. Michie HR, Spriggs DR, Manogue KR, et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery. 1988;104:280-286.
2. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science. 1986;234:470-474.
3. Imagawa DK, Millis KM, Olthoff P, et al. The role of tumor necrosis factor in allograft rejection: II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation. 1990;50:189-193.
4. Shalaby MR, Fendly B, Sheehan C, et al. Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha. Transplantation. 1989;47:1057-1062.
5. Piguet PF, Gray GE, Allet B, Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions in the acute phase of graft-vs-host disease. J Exp Med. 1987;166:1280-1289.
6. Holler E, Kolb HJ, Moller A, et al. Increased levels of tumor necrosis factor precede major complications of bone marrow transplantation. Blood. 1990;75:1011-1016.
7. Windsor AC, Walsh CJ, Mullen PG. Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest. 1993;91:1459-1468.
8. Suter PM, Suter S, Girardin E, et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145:1016-1022.
9. Ferrari-Baliviera E, Mealy K, Smith RJ, Wilmore DW. Tumor necrosis factor induces adult respiratory distress syndrome in rats. Arch Surg. 1989;124:1400-1405.
10. Peridiskii IV, Barshtein IA, Kudriavets II. Cytological features of the development of multi-organ failure induced by exposure of the body to tumor necrosis factor. Tsitol Genet. 1992;26:9-16.
11. Eichacker PQ, Huffman WD, Farese A, et al. TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J Appl Physiol. 1991;71:1979-1989.
12. Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993;103:565-575.
13. Mallick AA, Ishizaka A, Stephens KE, et al. Multiple organ damage caused by tumor necrosis factor and prevented by prior neutrophil depletion. Chest. 1989;95:1114-1120.
14. Wada H, Ohiwa M, Kaneko T, et al. Plasma level of tumor necrosis factor Ln disseminated intravascular coagulation. Am J Hematol. 1991;37:147-151.
15. Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effects of endotoxin. Science. 1985;229:869-874.
16. Michie HR, Spriggs DR, Manogue KR, et al. Tumor necrosis factor and endotoxin induce similar metaholic responses in human beings. Surgery. 1988;104:280-286.
17. Hughes CB, Gaber LW, Kotb M, et al. Induction of acute pancreatitis in germ-free rats: evidence of a primary role for TNF. Surgery. 1995;117:201-205.
18. Hughes CB, Henry J, Kotb M, et al. Up-regulation of TNF mRNA in the rat spleen following induction of acute pancreatitis. J Surg Res. 1995;59:687-693.
19. Grewal HP, Mohey el-Din AB, Gaber L, et al. Amelioration of the physiological and biochemical changes of acute pancreatitis using an anti-TNF polyclonal antibody. Am J Surg. 1994;167:214-219.
20. Renner IG, Savage WT, Pantoja JL, Renner VJ. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci. 1985;10:1005-1008.
21. Lankisch PG, Rahlf G, Koop H. Pulmonary complications in fatal haemorrhagic acute pancreatitis. Dig Dis Sci. 1983;28:111-116.
22. Guice KS, Oldham KT, Remick DG, et al. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J Surg Res. 1991;51:495-499.
23. Banks RE, Evans SW, Alexander D, et al. Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor alpha. Cytokine. 1991;3:12-16.
24. Exley A, Leese T, Holliday MP, et al. Endotoxemia and serum tumor necrosis factor as prognostic markers in severe acute pancreatitis. Gut. 1992;33:1126-1128.
25. Heath DI, Cruickshank A, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase response and potential as an early means of severity assessment in acute pancreatitis. Gut. 1993;34:41-45.
26. Leser HG, Gross V, Scheibenhogen C, et al. Elevation of serum inrerleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology. 1991;101:782-785.
27. Gross V, Andreesen R, Leser HG, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest. 1992;22:200-203.
28. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science. 1992;258:1957-1959.
29. Cavaillon JM. Contribution of cytokines to inflammatory mechanisms. Pathol Biol. (Paris) 1993;41:799-811.
30. Tsujimoto M, Yokota S, Vileck J, Wiessman G. Tumor necrosis factor provokes superoxide generation from neutrophils. Biochem Biophys Res. 1986;137:1094-1099.
31. Estrada C, Gomez C, Martin C, et al. Nitric acid mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells. Biochem Biophys Res Commun. 1992;186:475-482.
32. Bilchik AJ, Leach SD, Zucker KA, Modlin IM. Experimental models of acute pancreatitis. J Surg Res. 1990;48:639-647.
33. Windsor JA, Fearon KCH, Ross JA, et al. Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg. 1993;80:1042-1046.
34. Exley AR, Leese T, Holliday MP, et al. Endotoxaemia and serum tumor necrosis factor as prognostic markers in severe acute pancreatitis. Gut. 1992;33:1126-1128.
35. Sameshima H, Ikei S, Mori K, et al. The role of tumor necrosis factor in the aggravation of cerulein-induced pancreatitis in rats. Int J Poncreatol. 1993;14:107-115.
36. Tarpila E, Nystrom PO, Franzen L, Ihse I. Bacterial translocation during acute pancreatits in rats. Eur J Surg. 1993;159:109-113.
37. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. NEJM. 1988;318:1481-1486.
38. Rothstein JL, Schreiber H. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA. 1988;85:607-611.